SCHEMBL19842963

SCHEMBL19842963

Cc1nc(C)nc(-c2cccc3c4ccccc4n(-c4cccc5c4C(=O)N(c4ccccc4-c4ccccc4)C5=O)c23)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 1/20 0.43
▸ ALDH1A1 P00352 3/20 0.40
▸ HTT P42858 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ TYMS P04818 2/20 0.40
▸ POLB P06746 1/20 0.38
▸ MEN1 O00255 4/20 0.38
▸ KMT2A Q03164 4/20 0.38
▸ CASP3 P42574 1/20 0.37
▸ MGLL Q99685 1/20 0.36
▸ PDE6D O43924 1/20 0.36
▸ DUSP3 P51452 1/20 0.36
▸ LMNA P02545 2/20 0.35
▸ USP2 O75604 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ TNNI3 P19429 1/20 0.35
▸ TNNT2 P45379 1/20 0.35
▸ TNNC1 P63316 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ PDCD1 Q15116 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19842953 0.95 NR1H2 (0.45) NR1H2ALDH1A1HTTHSD17B10TYMS
SCHEMBL19843184 0.94 TYMS (0.37) NR1H2ALDH1A1HTTHSD17B10TYMS
SCHEMBL19843474 0.93 TYMS (0.46) NR1H2ALDH1A1HTTHSD17B10TYMS
SCHEMBL23476523 0.93 TYMS (0.35) NR1H2ALDH1A1HTTHSD17B10TYMS
SCHEMBL19843333 0.92 TYMS (0.43) NR1H2ALDH1A1HTTHSD17B10TYMS
SCHEMBL19843435 0.90 NR1H2 (0.45) NR1H2ALDH1A1HTTHSD17B10TYMS
SCHEMBL19843402 0.90 PDE6D (0.46) ALDH1A1HTTTYMSMEN1KMT2A
SCHEMBL19843256 0.89 TYMS (0.37) NR1H2ALDH1A1HTTTYMSPOLB
SCHEMBL19843195 0.88 TYMS (0.39) NR1H2ALDH1A1HTTHSD17B10TYMS
SCHEMBL19843024 0.88 TYMS (0.42) NR1H2ALDH1A1HTTHSD17B10TYMS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3494112-B1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2022-04-20 — — EP disclosed
US-20210171501-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2021-06-10 — — US disclosed
WO-2018024725-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-08 — — WO disclosed
EP-3279194-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210171501-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES L1CAM, OR10J3, AOX1 NR1H2 2382/4885ALDH1A1 20/4885HTT 4516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback